louisiana glp-1 intestinal paralysis lawsuit Ozempic Stomach Ozempic Lawsuit for Gastroparesis |

According to medRxiv's 2025 monitoring report, 71.8% of first-time prescriptions were for anti-diabetic medications, and 28.2% were for anti-obesity medications

Exp Ther Med 22:1167 Colhoun HM, Lingvay I, Brown PM, Deanfield J, Brown-Frandsen K, Kahn SE, Plutzky J, Node K, Parkhomenko A, Rydn L, Wilding JPH, Mann JFE, Tuttle KR, Idorn T, Rathor N, Lincoff AM (2024) Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

(2015) GLP-1 receptor agonists: a review of head-to-head clinical studies

Patients seeking GLP-1 therapy should consult healthcare providers about FDA-approved options